| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2020 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VANGUARD INDEX FDS | 16 | Q2 2024 | 82.8% |
| VANGUARD INDEX FDS | 14 | Q2 2024 | 42.2% |
| VANGUARD STAR FDS | 13 | Q2 2024 | 32.6% |
| VANGUARD SCOTTSDALE FDS | 12 | Q2 2024 | 7.4% |
| ISHARES TR | 11 | Q2 2024 | 16.0% |
| VANGUARD INTL EQUITY INDEX F | 11 | Q2 2024 | 4.0% |
| VANGUARD INDEX FDS | 10 | Q2 2024 | 13.7% |
| ISHARES TR | 8 | Q3 2019 | 62.5% |
| FGL HLDGS | 8 | Q3 2019 | 39.0% |
| VANGUARD INDEX FDS | 7 | Q2 2024 | 32.6% |
View OIKOS HOLDINGS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| MELINTA THERAPEUTICS, INC. /NEW/ | December 20, 2018 | 16,007,237 | 28.6% |
View OIKOS HOLDINGS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-07-31 |
| 13F-HR | 2024-05-13 |
| 13F-HR | 2024-02-02 |
| 13F-HR | 2023-11-01 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-04-27 |
| 13F-HR | 2023-01-26 |
| 13F-HR | 2022-11-02 |
| 13F-HR | 2022-07-28 |
| 13F-HR | 2022-04-28 |
View OIKOS HOLDINGS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.